Federal Register / Vol. 89, No. 21 / Wednesday, January 31, 2024 / Notices 6117 

III. What is the DfE program? 

The DfE program is a companion 

program to Safer Choice and certifies 

antimicrobial products. The DfE logo 

may be used on certified products and 

helps consumers and commercial 

buyers identify products that meet the 

health and safety standards of the 

pesticide registration process required 

by the Federal Insecticide, Fungicide, 

and Rodenticide Act (FIFRA) as well as 

the Safer Choice program’s stringent 

criteria for efficacy and effects on 

human health and the environment. For 

more information on the DfE program, 

please see: https://www.epa.gov/ 

pesticide-labels/learn-about-designenvironment-dfe-certification. 

IV. What is the purpose of the award? 

The purpose of the Partner of the Year 

Awards is to recognize the leadership 

contributions of Safer Choice program 

partners and stakeholders who, over the 

past year, have shown achievement in 

the design, manufacture, promotion, 

selection, and use of products with safer 

chemicals, that further outstanding or 

innovative source reduction. EPA 

especially encourages submission of 

award applications that show how the 

applicant’s work involving products 

with safer chemical ingredients 

promotes environmental justice, bolsters 

resilience to the impacts of climate 

change, results in cleaner air or water, 

improves drinking water quality, or 

advances innovation in packaging. 

Similar achievement in the design, 

manufacture, promotion, selection, and 

use of Design for the Environment (DfE)- 

certified products will also make an 

organization eligible for the Partner of 

the Year Awards. 

V. How can I participate? 

All Safer Choice stakeholders and 

program participants in good standing 

are eligible for recognition. Interested 

parties who would like to be considered 

for this award should submit to EPA an 

application detailing their 

accomplishments and contributions 

during calendar year 2023. The 

application form is available on the 

Safer Choice website. Candidates 

interested in learning more about the 

Partner of the Year Awards should refer 

to the following link: https://

www.epa.gov/saferchoice/safer-choicepartner-year-awards. EPA will recognize 

award winners at a Safer Choice Partner 

of the Year Awards ceremony later in 

2024. 

Authority: 42 U.S.C. 13103(b)(13) and 

15 U.S.C. 2609. 

Dated: January 26, 2024. 

Michal Freedhoff, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

[FR Doc. 2024–01909 Filed 1–30–24; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OAR–2023–0137; FRL–11708–01– 

OMS] 

Agency Information Collection 

Activities; Submission to the Office of 

Management and Budget for Review 

and Approval; Comment Request; New 

Source Performance Standards (NSPS) 

for Sewage Sludge Incineration Units 

(Renewal) 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Environmental Protection 

Agency (EPA) has submitted an 

information collection request (ICR), 

NSPS for Sewage Sludge Incineration 

Units (EPA ICR Number 2369.06, OMB 

Control Number 2060–0658), to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act. This is a proposed 

extension of the ICR, which is currently 

approved through January 31, 2024. 

Public comments were previously 

requested, via the Federal Register on 

May 18, 2023, during a 60-day comment 

period. This notice allows for an 

additional 30 days for public comments. 

DATES: Comments may be submitted on 

or before March 1, 2024. 

ADDRESSES: Submit your comments, 

referencing Docket ID Number EPA– 

HQ–OAR–2023–0137, to EPA online 

using www.regulations.gov/ (our 

preferred method), or by email to a-andr-docket@epa.gov, or by mail to: EPA 

Docket Center, Environmental 

Protection Agency, Mail Code 28221T, 

1200 Pennsylvania Ave. NW, 

Washington, DC 20460. The EPA’s 

policy is that all comments received 

will be included in the public docket 

without change, including any personal 

information provided, unless the 

comment includes profanity, threats, 

information claimed to be Confidential 

Business Information (CBI), or other 

information whose disclosure is 

restricted by statute. 

Submit written comments and 

recommendations to OMB for the 

proposed information collection within 

30 days of publication of this notice to: 

www.reginfo.gov/public/do/PRAMain. 

Find this specific information collection 

by selecting ‘‘Currently under Review— 

Open for Public Comments’’ or by using 

the search function. 

FOR FURTHER INFORMATION CONTACT: 

Muntasir Ali, Sector Policies and 

Program Division (D243–05), Office of 

Air Quality Planning and Standards, 

U.S. Environmental Protection Agency, 

Research Triangle Park, North Carolina, 

27711; telephone number: (919) 541– 

0833; email address: ali.muntasir@

epa.gov. 

SUPPLEMENTARY INFORMATION: This is a 

supporting extension of this ICR, which 

is currently approved through January 

31, 2024. An agency may neither 

conduct nor sponsor, and a person is 

not required to respond to, a collection 

of information unless it displays a 

currently valid OMB control number. 

Public comments were previously 

requested, via the Federal Register, on 

July 22, 2022, during a 60-day comment 

period (87 FR 43843) and May 18, 2023 

(88 FR 31748). This notice allows for an 

additional 30 days for public comments. 

Supporting documents, which explain 

in detail the information that the EPA 

will be collecting, are available in the 

public docket for this ICR. The docket 

can be viewed online at 

www.regulations.gov, or in person at the 

EPA Docket Center, WJC West Building, 

Room 3334, 1301 Constitution Ave. NW, 

Washington, DC. The telephone number 

for the Docket Center is 202–566–1744. 

For additional information about EPA’s 

public docket, visit http://www.epa.gov/ 

dockets. 

Abstract: The New Source 

Performance Standards for Sewage 

Sludge Incineration Units (40 CFR part 

60, subpart LLLL) were proposed on 

October 14, 2010; and promulgated on 

March 21, 2011. These regulations apply 

to new facilities with one or more 

sewage sludge incineration (SSI) units. 

New facilities are those that either 

commenced construction after October 

14, 2010, or commenced modification 

after September 21, 2011. Physical or 

operational changes made to the SSI 

unit to comply with the SSI Emission 

Guidelines at 40 CFR part 60, subpart 

MMMM do not qualify as a modification 

under this NSPS. This information is 

being collected to assure compliance 

with 40 CFR part 60, subpart LLLL. 

Form Numbers: None. 

Respondents/affected entities: Sewage 

Sludge Incinerators. 

Respondent’s obligation to respond: 

Mandatory (40 CFR part 60, subpart 

LLLL). 

Estimated number of respondents: 11 

(total). 


lotter on DSK11XQN23PROD with NOTICES1
6118 Federal Register / Vol. 89, No. 21 / Wednesday, January 31, 2024 / Notices 

Frequency of response: Semiannual, 

annual. 

Total estimated burden: 1,800 hours 

(per year). Burden is defined at 5 CFR 

1320.3(b). 

Total estimated cost: $1,950,000 (per 

year), which includes $1,850,000 in 

annualized capital/startup and/or 

operation & maintenance costs. 

Changes in the Estimates: The 

increase in burden from the mostrecently approved ICR is due to an 

increase in the number of new or 

modified sources. There is also an 

increase in costs due to the use of 

updated labor rates. This ICR uses labor 

rates from the most-recent Bureau of 

Labor Statistics report (September 2022) 

to calculate respondent burden costs. 

This ICR also adjusts the capital/startup 

and operation and maintenance costs 

from 2008 to 2022 values using the 

CEPCI CE Index. 

Courtney Kerwin, 

Director, Regulatory Support Division. 

[FR Doc. 2024–01807 Filed 1–30–24; 8:45 am] 

BILLING CODE 6560–50–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10788] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

April 1, 2024. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number ll: Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10788 Prescription Drug and 

Health Care Spending 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Prescription 

Drug and Health Care Spending; Use: 

On December 27, 2020, the 

Consolidated Appropriations Act, 2021 

(CAA) was signed into law. Section 204 

of title II of division BB of the CAA 

added parallel provisions at section 

9825 of the Internal Revenue Code (the 

Code), section 725 of the Employee 

Retirement Income Security Act 

(ERISA), and section 2799A–10 of the 

Public Health Service Act (PHS Act) 

that require group health plans and 

health insurance issuers offering group 

or individual health insurance coverage 

to annually report to the Department of 

the Treasury, the Department of Labor 

(DOL), and the Department of Health 

and Human Services (HHS) 

(collectively, ‘‘the Departments’’) certain 

information about prescription drug and 

health care spending, premiums, and 

enrollment under the plan or coverage. 

This information will support the 

development of public reports that will 

be published by the Departments on 

prescription drug reimbursements for 

plans and coverage, prescription drug 

pricing trends, and the role of 

prescription drug costs in contributing 

to premium increases or decreases 

under the plans or coverage. The 2021 

interim final rules, ‘‘Prescription Drug 

and Health Care Spending’’ (2021 

interim final rules), issued by the 

Departments and the Office of Personnel 

Management (OPM) implement the 

provisions of section 9825 of the Code, 

section 725 of ERISA, and section 

2799A–10 of the PHS Act, as enacted by 

section 204 of title II of division BB of 

the CAA. OPM joined the Departments 

in issuing the 2021 interim final rules, 

requiring Federal Employees Health 

Benefits (FEHB) carriers to report 

information about prescription drug and 

health care spending, premiums, and 

plan enrollment in the same manner as 

a group health plan or health insurance 

issuer offering group or individual 

health insurance coverage. 

The 2023 Prescription Drug Data 

Collection (RxDC) Reporting 

Instructions reflect changes for the 2023 

reference year and beyond. As a result 

of removing one-time first- and secondVerDate Sep<11>2014 17:00 Jan 30, 2024 Jkt 262001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\31JAN1.SGM 31JAN1

lotter on DSK11XQN23PROD with NOTICES1